comparemela.com

Page 2 - Equity Funds Management News Today : Breaking News, Live Updates & Top Stories | Vimarsana

China Digest: DCM, Lightspeed back oral care brand BOP; Genskey bags $15m

China Digest: Dearer nets $65m; Temasek backs Abiochem

China Digest: Dearer nets $65m; Temasek backs Abiochem Dearer nets $65m in Series B Shanghai-headquartered contact lens manufacturer Dearer has raised 420 million yuan ($65 million) in a Series B round of financing.  State-backed alternative asset manager CITIC Private Equity Funds Management (CPE), Legend Holdings’ investment arm Legend Capital and BioTrack Capital joined the round. Insight Capital made a follow-on investment in the round.  The company will use the proceeds for R&D and mass production of coloured contact lenses, the company said in a statement.  Its early-stage investors include Orient Securities, Borchid Capital,  FOF Capital and eyecare service provider Eyebright.  Temasek invests in Abiochem 

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.